🔎 Trials Near Me

Akèy › Skleroz Miltip › Wisconsin

Etid klinik pou Skleroz Miltip nan Wisconsin

7 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Wisconsin.

Vil nan Wisconsin

Tèks ofisyèl etid la (Anglè)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Greenfield
  • TG Therapeutics Investigational Trial Site, Milwaukee
  • TG Therapeutics Investigational Trial Site, Neenah
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • University of Wisconsin at Madison, Madison
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Sep 10, 2026 · NCT06408259

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

  • TG Therapeutics Investigational Trial Site, Milwaukee
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

  • Research Site, Milwaukee
Ap rekriteFaz 1
Laj 18 a 60 · Tout sèks · Mizajou Aug 25, 2026 · NCT07224373

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

  • Brain Inflammation Collaborative, Delafield
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 ak plis · Tout sèks · Mizajou Jan 22, 2026 · NCT04806620

High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis

  • Marquette University, Milwaukee
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou Jun 5, 2024 · NCT05735691

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.